Vaccination greatly reduces disease, disability, death and inequity worldwide.
暂无分享,去创建一个
H Peltola | J. Clemens | M. Santosham | R. Booy | H. Schmitt | H. Peltola | F. André | H. Bock | J. Clemens | S. Datta | T. John | B. W. Lee | S. Lolekha | T. Ruff | M Santosham | B. Lee | H. Bock | H J Schmitt | F E Andre | R Booy | H L Bock | J Clemens | S K Datta | T J John | B W Lee | S Lolekha | T A Ruff | T. Ruff | FE Andre | SK Datta
[1] H. Maguire,et al. Large outbreak of measles in London: reversal of health inequalities , 2005, Archives of Disease in Childhood.
[2] J. Ehreth. The global value of vaccination. , 2003, Vaccine.
[3] T. Vesikari,et al. Safety and efficacy of an attenuated vaccine against severe rotavirus gastroenteritis. , 2006, The New England journal of medicine.
[4] R. von Kries,et al. Haemophilus influenzae type b disease: impact and effectiveness of diphtheria-tetanus toxoids-acellular pertussis (-inactivated poliovirus)/H. influenzae type b combination vaccines. , 2001, The Pediatric infectious disease journal.
[5] J. Hedlund,et al. Additive preventive effect of influenza and pneumococcal vaccines in elderly persons , 2004, European Respiratory Journal.
[6] P. Rota,et al. Implications of a 2005 measles outbreak in Indiana for sustained elimination of measles in the United States. , 2006, The New England journal of medicine.
[7] J. Goedert,et al. The Gambia Liver Cancer Study: Infection with hepatitis B and C and the risk of hepatocellular carcinoma in West Africa , 2004, Hepatology.
[8] D. Sack,et al. Herd immunity conferred by killed oral cholera vaccines in Bangladesh: a reanalysis , 2005, The Lancet.
[9] R. Adegbola,et al. Elimination of Haemophilus influenzae type b (Hib) disease from The Gambia after the introduction of routine immunisation with a Hib conjugate vaccine: a prospective study , 2005, The Lancet.
[10] L. Moulton,et al. Estimation of the indirect effect of Haemophilus influenzae type b conjugate vaccine in an American Indian population. , 2000, International journal of epidemiology.
[11] F. André. What can be done to make vaccines more trendy? , 2005, Expert review of vaccines.
[12] L. Hessel,et al. Declining pertussis incidence in Sweden following the introduction of acellular pertussis vaccine. , 2003, Vaccine.
[13] M. Miller,et al. Policy analysis of the use of hepatitis B, Haemophilus influenzae type b-, Streptococcus pneumoniae-conjugate and rotavirus vaccines in national immunization schedules. , 2000, Health economics.
[14] Adam Wagstaff,et al. Poverty and health sector inequalities. , 2002, Bulletin of the World Health Organization.
[15] R. May,et al. Infectious Diseases of Humans: Dynamics and Control , 1991, Annals of Internal Medicine.
[16] S. Plotkin,et al. Mass Vaccination : Global Aspects - Progress and Obstacles , 2006 .
[17] J. Stockman. Impact of Childhood Vaccination on Racial Disparities in Invasive Streptococcus pneumoniae Infections , 2006 .
[18] M Elizabeth Halloran,et al. Effects of pertussis vaccination on disease: vaccine efficacy in reducing clinical severity. , 2003, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[19] R. Steffen,et al. Vaccination priorities. , 2003, International journal of antimicrobial agents.
[20] C. Macintyre,et al. Immunization myths and realities: Responding to arguments against immunization , 2003, Journal of paediatrics and child health.
[21] J. Lieberman. Appropriate antibiotic use and why it is important: the challenges of bacterial resistance , 2003, The Pediatric infectious disease journal.
[22] A. B. CiusnE,et al. Typhoid fever. , 1967, The Journal of the Arkansas Medical Society.
[23] Fletcher T Djelantik IG,et al. WHO Position Paper on Haemophilus influenzae Vaccines , 2006 .
[24] Reuben Samuel,et al. Herd immunity and herd effect: new insights and definitions , 2004, European Journal of Epidemiology.
[25] L. Pirofski,et al. Vaccines for the prevention of diseases caused by potential bioweapons. , 2004, Clinical immunology.
[26] A. Wilder-Smith,et al. Sustained outbreak of W135 meningococcal disease in east London, UK , 2002, The Lancet.
[27] M. Gahr,et al. Efficacy of acellular pertussis vaccine in early childhood after household exposure. , 1996, JAMA.
[28] O. Heinonen,et al. Mumps and rubella eliminated from Finland. , 2000, JAMA.
[29] A. Siitonen,et al. Prevention of travellers' diarrhoea by oral B-subunit/whole-cell cholera vaccine , 1991, The Lancet.
[30] P. van Damme,et al. Lifelong protection against hepatitis B: the role of vaccine immunogenicity in immune memory. , 2000, Vaccine.
[31] A. Shearley,et al. The societal value of vaccination in developing countries. , 1999, Vaccine.
[32] Ziad A Memish,et al. Health risks at the Hajj , 2006, The Lancet.
[33] S. Gatchalian,et al. Facilitating the WHO expanded program of immunization: the clinical profile of a combined diphtheria, tetanus, pertussis, hepatitis B and Haemophilus influenzae type b vaccine. , 2003, International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases.
[34] N. Walker,et al. Neonatal survival: a call for action , 2005, The Lancet.
[35] P. Kaye. Infectious diseases of humans: Dynamics and control , 1993 .
[36] D. Bishai,et al. Measles vaccination improves the equity of health outcomes: evidence from Bangladesh. , 2003, Health economics.
[37] D. Henderson,et al. Lessons from the eradication campaigns. , 1999, Vaccine.
[38] Mei-Hwei Chang,et al. Decreasing incidence of hepatocellular carcinoma among children following universal hepatitis B immunization , 2003, Liver international : official journal of the International Association for the Study of the Liver.
[39] Robert T. Chen,et al. Morbidity and Mortality Weekly Report , 2002 .
[40] P. Kunasol,et al. Protection against hepatitis A by an inactivated vaccine. , 1994, JAMA.
[41] R. Succi,et al. Vaccination in special situations. , 2006, Jornal de pediatria.
[42] Impact of vaccines universally recommended for children--United States, 1990-1999. , 1999, Canada communicable disease report = Releve des maladies transmissibles au Canada.
[43] W. Schaffner,et al. Effect of introduction of the pneumococcal conjugate vaccine on drug-resistant Streptococcus pneumoniae. , 2006, The New England journal of medicine.
[44] S. Schrag,et al. Impact of childhood vaccination on racial disparities in invasive Streptococcus pneumoniae infections. , 2004, JAMA.
[45] J. Hanna,et al. Impact of hepatitis A vaccination of Indigenous children on notifications of hepatitis A in north Queensland , 2004, The Medical journal of Australia.
[46] M. Halloran,et al. Cost-effectiveness of a routine varicella vaccination program for US children. , 1994, JAMA.
[47] S. Ellenberg,et al. A global perspective on vaccine safety and public health: the Global Advisory Committee on Vaccine Safety. , 2004, American journal of public health.
[48] E. Shapiro,et al. Effectiveness over time of varicella vaccine. , 2004, JAMA.
[49] John Mullooly,et al. Influenza vaccination and reduction in hospitalizations for cardiac disease and stroke among the elderly. , 2003, The New England journal of medicine.
[50] S. Hadler,et al. Measles Herd Immunity: The Association of Attack Rates With Immunization Rates in Preschool Children , 1992 .
[51] D. Canning,et al. The Value of Vaccination , 1897, British medical journal.
[52] M. Decker. Principles of pediatric combination vaccines and practical issues related to use in clinical practice , 2001, The Pediatric infectious disease journal.
[53] Q. Mok,et al. Severe and unrecognised: pertussis in UK infants , 2003, Archives of disease in childhood.
[54] D. Gertig,et al. Lombok Hepatitis B Model Immunization Project: toward universal infant hepatitis B immunization in Indonesia. , 1995, The Journal of infectious diseases.
[55] T. Scott,et al. Measles vaccine , 2018, Reactions Weekly.
[56] F. André. Universal mass vaccination against hepatitis A. , 2006, Current topics in microbiology and immunology.
[57] C. Wheeler,et al. Sustained efficacy up to 4·5 years of a bivalent L1 virus-like particle vaccine against human papillomavirus types 16 and 18: follow-up from a randomised control trial , 2006, The Lancet.
[58] A. Fiore,et al. Hepatitis A transmitted by food. , 2004, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[59] P. Fine,et al. Global poliomyelitis eradication: status and implications , 2007, The Lancet.
[60] S. Obaro,et al. Efficacy of nine-valent pneumococcal conjugate vaccine against pneumonia and invasive pneumococcal disease in The Gambia: randomised, double-blind, placebo-controlled trial , 2005, The Lancet.
[61] P. Hotez. Vaccines as instruments of foreign policy , 2001, EMBO reports.
[62] Antonio Boccia,et al. The Efficacy of Influenza Vaccine for Healthy Children: A Meta-Analysis Evaluating Potential Sources of Variation in Efficacy Estimates Including Study Quality , 2007, The Pediatric infectious disease journal.
[63] I. Chabot,et al. The societal value of universal childhood vaccination. , 2004, Vaccine.
[64] J. Best,et al. Reducing global disease burden of measles and rubella: report of the WHO Steering Committee on research related to measles and rubella vaccines and vaccination, 2005. , 2007, Vaccine.